Expanding upon these clinical observations, we have demonstrated that melanoma patients with elevated cGAS levels also exhibit increased expression of CCL5 and CXCL10, as illustrated in (Fig. S7B, upper panels). This evidence concerns the gene CXCL10 and melanoma.